Zinplava

bezlotoxumab · Merck & Co.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Zinplava, covering 2016-10-21 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection [Phase 2]